DISPERSE2-TIMI 33 evaluated the safety, tolerability, and efficacy of AZD6140 (ticagrelor), an oral reversible ADP receptor antagonist, compared with clopidogrel in patients with non-ST segment elevation acute coronary syndrome.
DISPERSE2-TIMI 33 evaluated the safety, tolerability, and efficacy of AZD6140 (ticagrelor), an oral reversible ADP receptor antagonist, compared with clopidogrel in patients with non-ST segment elevation acute coronary syndrome.